Innohep and Lonsurf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Innohep (tinzaparin sodium) and Lonsurf (tipiracil hydrochloride; trifluridine). Common drug interactions include pleural effusion among females and diarrhoea haemorrhagic among males.

The phase IV clinical study analyzes what interactions people have when they take Innohep and Lonsurf. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Innohep?

Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 9,243 Innohep users. Check the latest studies of Innohep.

What is Lonsurf?

Lonsurf has active ingredients of tipiracil hydrochloride; trifluridine. eHealthMe is studying from 10,077 Lonsurf users. Check the latest studies of Lonsurf.

On Jul, 06, 2026

11 people who take Innohep and Lonsurf together, and have interactions are studied.

What are the common drug interactions of Innohep and Lonsurf, by gender? *:

female:

Pleural effusion (water on the lungs)
Device related infection
Ascites (accumulation of fluid in the abdominal cavity)
Disease progression
Drug intolerance (drug sensitivity)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Pneumonia
Rash
Septic shock (shock due to blood infection)
Malignant neoplasm progression (cancer tumour came back)

male:

Diarrhoea haemorrhagic (bloody diarrhoea)
Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
General symptom
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Pain
Subileus

What are the common drug interactions of Innohep and Lonsurf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Malignant neoplasm progression (cancer tumour came back)
Oedema peripheral (superficial swelling)
Pleural effusion (water on the lungs)
Device related infection
Ascites (accumulation of fluid in the abdominal cavity)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Rash
Jugular vein thrombosis (clot in jugular vein)

50-59:

Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

60+:

Diarrhoea haemorrhagic (bloody diarrhoea)
Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Malignant neoplasm progression (cancer tumour came back)
Disease progression
Drug intolerance (drug sensitivity)
Pneumonia
Septic shock (shock due to blood infection)
Subileus

What are the existing conditions these people have? *

Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 7 people, 63.64%
High Blood Pressure: 5 people, 45.45%
Nausea (feeling of having an urge to vomit): 5 people, 45.45%
Stress And Anxiety: 5 people, 45.45%
Bleeding Disorders: 4 people, 36.36%
Gastrointestinal Infection (infection of stomach and intestine): 3 people, 27.27%
Pain: 3 people, 27.27%
Hypokalemia (low potassium): 3 people, 27.27%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 2 people, 18.18%
Abdominal Pain: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Innohep and Lonsurf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously